FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns an agent for extreme performance stimulation in the form of a mixture of peptides of molecular weight 2000-5000 Da and peptides of molecular weight 500-900 Da prepared of the infant cattle and/or swine brain in ratio of the ingredients 2/1-3/1, in the concentration of the mixture of peptides in the agent of 5.0-10.0 mg/ml of the aqueous solution or 5.0-10.0 mg/g in the witepsol suppository; a method for preparing the above agent for extreme performance stimulation; using the above agent for parenteral administration or for rectal administration.
EFFECT: group of inventions provides higher performance efficiency and tolerance in trained individuals at least by 20% as compared with the reference group.
3 cl, 5 ex, 4 dwg, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR EXTREME PERFORMANCE STIMULATION | 2012 |
|
RU2503457C2 |
| AGENT FOR EXTREME PERFORMANCE STIMULATION, METHOD FOR PREPARING AND USING IT | 2012 |
|
RU2496504C1 |
| METHOD FOR STUDYING KINESIODYNAMICS AND BEHAVIOUR OF TEST ANIMALS | 2012 |
|
RU2520155C1 |
| WATER CHANNEL BY KARKISCHENKO WITH ARTIFICIAL FLOW FOR RESEARCH OF KINESIDYNAMICS OF EXPERIMENTAL ANIMALS | 2012 |
|
RU2518096C1 |
| "MIOACTIVE-SPORT" FOOD PRODUCT FOR ALIMENTATION OF PEOPLE EXPERIENCING INTENSIVE PHYSICAL STRAIN | 2012 |
|
RU2520036C2 |
| SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION IN THE FORM OF A SUPPOSITORY CONTAINING HEXAPEPTIDE | 2020 |
|
RU2737800C1 |
| HEPTAPEPTIDE AMIDES FOR THE TREATMENT OF HMGB1-DEPENDENT DISEASES | 2021 |
|
RU2760133C1 |
| TEST SYSTEM FOR DETECTION OF EXPRESSION OF NAT2 GENES OF HUMAN BEING | 2014 |
|
RU2580005C1 |
| ANTIHYPOXIC AGENT | 1994 |
|
RU2098085C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
